{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:00:21Z","timestamp":1790643621560,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13193-025-02513-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:23:20Z","timestamp":1769509400000},"page":"2076-2085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Susceptibility Weighted and Perfusion Imaging for Differentiating Recurrence and Radiation Necrosis in Post-Operative Malignant Brain Tumors: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"17","author":[{"given":"Muhammad Saqlain","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain Sohail","family":"Rangwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Memoona","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ashir","family":"Shafique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janta","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Taha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"10","key":"2513_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"23","key":"2513_CR2","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B et al (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318(23):2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"issue":"3","key":"2513_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/nop\/npae004","volume":"11","author":"TH Beckham","year":"2024","unstructured":"Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S et al (2024) Hypofractionated radiotherapy for glioblastoma: a large institutional retrospective assessment of 2 approaches. Neuro-Oncol Pract 11(3):266\u2013274. https:\/\/doi.org\/10.1093\/nop\/npae004","journal-title":"Neuro-Oncol Pract"},{"issue":"23","key":"2513_CR4","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1158\/0008-5472.Can-21-0752","volume":"81","author":"E Fletcher-Sananikone","year":"2021","unstructured":"Fletcher-Sananikone E, Kanji S, Tomimatsu N, Di Cristofaro LFM, Kollipara RK, Saha D et al (2021) Elimination of radiation-induced senescence in the brain tumor microenvironment attenuates glioblastoma recurrence. Cancer Res 81(23):5935\u20135947. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0752","journal-title":"Cancer Res"},{"issue":"4","key":"2513_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jnci.2016.07.001","volume":"28","author":"S Mallick","year":"2016","unstructured":"Mallick S, Benson R, Hakim A, Rath GK (2016) Management of glioblastoma after recurrence: a changing paradigm. J Egypt Natl Canc Inst 28(4):199\u2013210. https:\/\/doi.org\/10.1016\/j.jnci.2016.07.001","journal-title":"J Egypt Natl Canc Inst"},{"issue":"12","key":"2513_CR6","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang L, Jung J, Babikir H, Shamardani K, Jain S, Feng X et al (2022) A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat Cancer 3(12):1534\u20131552. https:\/\/doi.org\/10.1038\/s43018-022-00475-x","journal-title":"Nat Cancer"},{"issue":"4","key":"2513_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.5306\/wjco.v15.i4.482","volume":"15","author":"B Lucke-Wold","year":"2024","unstructured":"Lucke-Wold B, Rangwala BS, Shafique MA, Siddiq MA, Mustafa MS, Danish F et al (2024) Focus on current and emerging treatment options for glioma: a comprehensive review. World J Clin Oncol 15(4):482\u2013495. https:\/\/doi.org\/10.5306\/wjco.v15.i4.482","journal-title":"World J Clin Oncol"},{"issue":"7","key":"2513_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMoa2304194","volume":"389","author":"IK Mellinghoff","year":"2023","unstructured":"Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J et al (2023) Vorasidenib in IDH1- or IDH2-mutant low-grade glioma. N Engl J Med 389(7):589\u2013601. https:\/\/doi.org\/10.1056\/NEJMoa2304194","journal-title":"N Engl J Med"},{"issue":"12","key":"2513_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","volume":"389","author":"E Bouffet","year":"2023","unstructured":"Bouffet E, Hansford JR, Garr\u00e8 ML, Hara J, Plant-Fox A, Aerts I et al (2023) Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med 389(12):1108\u20131120. https:\/\/doi.org\/10.1056\/NEJMoa2303815","journal-title":"N Engl J Med"},{"issue":"6","key":"2513_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/s1470-2045(21)00090-5","volume":"22","author":"MJ van den Bent","year":"2021","unstructured":"van den Bent MJ, Tesileanu CMS, Wick W, Sanson M, Brandes AA, Clement PM et al (2021) Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053\u201322054): second interim analysis of a randomised, open-label, phase 3 study. Lancet Oncol 22(6):813\u2013823. https:\/\/doi.org\/10.1016\/s1470-2045(21)00090-5","journal-title":"Lancet Oncol"},{"key":"2513_CR11","doi-asserted-by":"publisher","unstructured":"da Hygino Cruz LC Jr., Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG (2011) Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 32(11):1978\u201385. https:\/\/doi.org\/10.3174\/ajnr.A2397","DOI":"10.3174\/ajnr.A2397"},{"issue":"1","key":"2513_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/nop\/npad063","volume":"11","author":"H Blakstad","year":"2024","unstructured":"Blakstad H, Mendoza Mireles EE, Heggeb\u00f8 LC, Magelssen H, Sprauten M, Johannesen TB et al (2024) Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: a cohort study. Neurooncol Pract 11(1):36\u201345. https:\/\/doi.org\/10.1093\/nop\/npad063","journal-title":"Neurooncol Pract"},{"issue":"1","key":"2513_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08004-2","volume":"21","author":"J Xi","year":"2021","unstructured":"Xi J, Hassan B, Katumba RGN, Khaddour K, Govindan A, Luo J et al (2021) The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma. BMC Cancer 21(1):285. https:\/\/doi.org\/10.1186\/s12885-021-08004-2","journal-title":"BMC Cancer"},{"key":"2513_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6828396","volume":"2018","author":"A Zikou","year":"2018","unstructured":"Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI (2018) Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast Media Mol Imaging 2018:6828396. https:\/\/doi.org\/10.1155\/2018\/6828396","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"2513_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pbc.25179","volume":"62","author":"RP Naftel","year":"2015","unstructured":"Naftel RP, Pollack IF, Zuccoli G, Deutsch M, Jakacki RI (2015) Pseudoprogression of low-grade gliomas after radiotherapy. Pediatr Blood Cancer 62(1):35\u201339. https:\/\/doi.org\/10.1002\/pbc.25179","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2513_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D, Stalpers L, Taal W, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9(5):453\u2013461. https:\/\/doi.org\/10.1016\/s1470-2045(08)70125-6","journal-title":"Lancet Oncol"},{"issue":"11","key":"2513_CR17","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/jco.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28(11):1963\u20131972. https:\/\/doi.org\/10.1200\/jco.2009.26.3541","journal-title":"J Clin Oncol"},{"issue":"10","key":"2513_CR18","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1007\/s00330-018-5356-8","volume":"28","author":"A Lecler","year":"2018","unstructured":"Lecler A, Charbonneau F, Psimaras D, Metten M-A, Gueguen A, Hoang Xuan K et al (2018) Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy. Eur Radiol 28(10):4324\u20134333. https:\/\/doi.org\/10.1007\/s00330-018-5356-8","journal-title":"Eur Radiol"},{"issue":"9","key":"2513_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.acra.2007.05.013","volume":"14","author":"M Akter","year":"2007","unstructured":"Akter M, Hirai T, Hiai Y, Kitajima M, Komi M, Murakami R et al (2007) Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies. Acad Radiol 14(9):1011\u20131019. https:\/\/doi.org\/10.1016\/j.acra.2007.05.013","journal-title":"Acad Radiol"},{"issue":"Suppl 1","key":"2513_CR20","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13(Suppl 1):S31\u2013S34. https:\/\/doi.org\/10.4103\/sja.SJA_543_18","journal-title":"Saudi J Anaesth"},{"key":"2513_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790674","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Ma Y, Wu Z, Xie R, Zeng F, Cai H et al (2021) Advanced imaging techniques for differentiating pseudoprogression and tumor recurrence after immunotherapy for glioblastoma. Front Immunol 12:790674. https:\/\/doi.org\/10.3389\/fimmu.2021.790674","journal-title":"Front Immunol"},{"issue":"3","key":"2513_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.nurt.2009.05.002","volume":"6","author":"S Cha","year":"2009","unstructured":"Cha S (2009) Neuroimaging in neuro-oncology. Neurotherapeutics 6(3):465\u2013477. https:\/\/doi.org\/10.1016\/j.nurt.2009.05.002","journal-title":"Neurotherapeutics"},{"issue":"Suppl 4","key":"2513_CR23","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.4103\/2152-7806.111298","volume":"4","author":"KR Fink","year":"2013","unstructured":"Fink KR, Fink JR (2013) Imaging of brain metastases. Surg Neurol Int 4(Suppl 4):S209\u2013S219. https:\/\/doi.org\/10.4103\/2152-7806.111298","journal-title":"Surg Neurol Int"},{"issue":"1","key":"2513_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.14791\/btrt.2015.3.1.8","volume":"3","author":"MC Mabray","year":"2015","unstructured":"Mabray MC, Barajas RF, Cha S (2015) Modern brain tumor imaging. Brain Tumor Res Treat 3(1):8\u201323","journal-title":"Brain Tumor Res Treat"},{"issue":"2","key":"2513_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11060-013-1178-3","volume":"114","author":"SG Berntsson","year":"2013","unstructured":"Berntsson SG, Falk A, Savitcheva I, Godau A, Zetterling M, Hesselager G et al (2013) Perfusion and diffusion MRI combined with 11C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neurooncol 114(2):241\u2013249. https:\/\/doi.org\/10.1007\/s11060-013-1178-3","journal-title":"J Neurooncol"},{"issue":"11","key":"2513_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.clon.2014.06.010","volume":"26","author":"R Jakubovic","year":"2014","unstructured":"Jakubovic R, Sahgal A, Soliman H, Milwid R, Zhang L, Eilaghi A et al (2014) Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases. Clin Oncol (R Coll Radiol) 26(11):704\u2013712. https:\/\/doi.org\/10.1016\/j.clon.2014.06.010","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"2513_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00234-013-1297-8","volume":"56","author":"W Bian","year":"2014","unstructured":"Bian W, Hess CP, Chang SM, Nelson SJ, Lupo JM (2014) Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T. Neuroradiology 56(2):91\u201396. https:\/\/doi.org\/10.1007\/s00234-013-1297-8","journal-title":"Neuroradiology"},{"key":"2513_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107368","volume":"221","author":"A Rubin","year":"2022","unstructured":"Rubin A, Waszczuk \u0141, Trybek G, Kapetanakis S, Bladowska J (2022) Application of susceptibility weighted imaging (SWI) in diagnostic imaging of brain pathologies - a practical approach. Clin Neurol Neurosurg 221:107368. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107368","journal-title":"Clin Neurol Neurosurg"},{"key":"2513_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.787755","volume":"16","author":"LR Carrete","year":"2022","unstructured":"Carrete LR, Young JS, Cha S (2022) Advanced imaging techniques for newly diagnosed and recurrent gliomas. Front Neurosci 16:787755. https:\/\/doi.org\/10.3389\/fnins.2022.787755","journal-title":"Front Neurosci"},{"key":"2513_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.compmedimag.2023.102218","volume":"106","author":"T Zhou","year":"2023","unstructured":"Zhou T, Noeuveglise A, Modzelewski R, Ghazouani F, Thureau S, Fontanilles M et al (2023) Prediction of brain tumor recurrence location based on multi-modal fusion and nonlinear correlation learning. Comput Med Imaging Graph 106:102218. https:\/\/doi.org\/10.1016\/j.compmedimag.2023.102218","journal-title":"Comput Med Imaging Graph"},{"issue":"3","key":"2513_CR31","first-page":"211","volume":"93","author":"A Perkins","year":"2016","unstructured":"Perkins A, Liu G (2016) Primary brain tumors in adults: diagnosis and treatment. Am Fam Physician 93(3):211\u2013217","journal-title":"Am Fam Physician"},{"issue":"10","key":"2513_CR32","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1055-9965.Epi-14-0275","volume":"23","author":"JP Thakkar","year":"2014","unstructured":"Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS et al (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23(10):1985\u20131996. https:\/\/doi.org\/10.1158\/1055-9965.Epi-14-0275","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2513_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11060-015-1928-5","volume":"125","author":"NJ Mickevicius","year":"2015","unstructured":"Mickevicius NJ, Carle AB, Bluemel T, Santarriaga S, Schloemer F, Shumate D et al (2015) Location of brain tumor intersecting white matter tracts predicts patient prognosis. J Neurooncol 125(2):393\u2013400. https:\/\/doi.org\/10.1007\/s11060-015-1928-5","journal-title":"J Neurooncol"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-025-02513-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:21:57Z","timestamp":1790641317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-025-02513-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2513"],"URL":"https:\/\/doi.org\/10.1007\/s13193-025-02513-3","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"value":"0975-7651","type":"print"},{"value":"0976-6952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional review board approval was waived from the Ethics Committee of Aga Khan University due to the retrospective nature of this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest concerning the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}